Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for MJN
-0.03 (-0.03%)
Apr 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 88.68 - 88.80
52 week 69.25 - 94.40
Open 88.75
Vol / Avg. 3.62M/2.14M
Mkt cap 16.29B
P/E 27.83
Div/yield 0.41/1.86
EPS 3.19
Shares 183.70M
Beta 1.48
Inst. own 98%
Jul 27, 2017
Q2 2017 Mead Johnson Nutrition Co Earnings Release - Tentative - 9:30AM EDT - Add to calendar
May 11, 2017
Mead Johnson Nutrition Co Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
Apr 27, 2017
Q1 2017 Mead Johnson Nutrition Co Earnings Release
Feb 10, 2017
Reckitt Benckiser Group PLC Conference Call to Discuss Definitive Agreement to Acquire Mead Johnson Nutrition Company and Full Year 2016 Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 13.31% 14.68%
Operating margin 17.56% 21.87%
EBITD margin - 26.59%
Return on average assets 11.35% 13.59%
Return on average equity - -
Employees 7,600 -
CDP Score - A-


2701 Patriot Blvd Fl 4
GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Michel M.G. Cup Chief Financial Officer, Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Charles M. Urbain Chief Operating Officer, Executive Vice President
Age: 62
Bio & Compensation  - Reuters
Patrick M. Sheller Senior Vice President, General Counsel, Secretary
Age: 55
Bio & Compensation  - Reuters
James E. Shiah Senior Vice President, Corporate Controller
Age: 57
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Technical Operations
Age: 57
Bio & Compensation  - Reuters
Ian Eric Ormesher Senior Vice President- Global Human Resources
Age: 54
Bio & Compensation  - Reuters
Dirk Hondmann Ph.D. Chief Scientific Officer
Age: 53
Bio & Compensation  - Reuters
James M. Cornelius Non-Executive Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Stephen W. Golsby Director
Age: 61
Bio & Compensation  - Reuters